Trial intelligence / Profile preview

Natriuretic Peptide Response to Saline Infusion

NCT04223531Completed

Sponsor
Vanderbilt University Medical Center
Start
Oct 2020
Primary completion
Jun 2022
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Vanderbilt University Medical Center. Primary endpoints: Change in circulating levels of proBNP 1-108 at 6 hours and Change in circulating levels of proBNP 1-32 at 6 hours. Started Oct 2020; status: completed.

Beyond the preview

Go deeper on NCT04223531.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04223531.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call